An enzyme immunoassay for gentamicin utilizing glucose -6-phosphate dehydrogenase was compared to the radioimmunoassay. The enzyme immunoassay for gentamicin was accurate, specific, and easily performed. It offers an alternative method to assay aminoglycosides and could be used in institutions using enzyme immunoassay to assay other drugs.
Aminoglycoside antibiotics-gentamicin, tobramycin, amikacin-have proved to be extremely useful agents in the chemotherapy of serious infections due to gram-negative aerobic bacteria (1). However, initial enthusiasm over these agents has been muted by a realization that the toxic-to-therapeutic ratio is narrow (1, 2). Furthermore, a number of studies have shown that failure of these agents to cure certain infections may be related to inadequate serum levels of the agents (1). Although serum levels have proved to be extremely predictable in the healthy, male volunteers used to evaluate the initial clinical pharmacology of these drugs, patient serum levels have proved to be less predictable and the necessity of monitoring serum levels is generally accepted (2, 8) .
Bioassays of serum levels of aminoglycosides are reliable if careful attention is given to the problems inherent in these assays (10) . However, the results are not available as rapidly as needed to make initial dosage adjustments. The use of adenylating enzymes as an assay method utilizing [1'C]adenosine triphosphate has been limited primarily to research laboratories, although the results are obtained rapidly and accuracy is good (6, 11) . Radioimmunoassay (RIA) has been the most common method used to assay levels. This technique also has problems attendant with its use.
Homogenous enzyme immunoassay (EIA) was introduced in 1972 (9) . The technique has been utilized widely to monitor serum levels of antiepileptic agents, asthma medications, and cardiac drugs, and to monitor thyroid function (4, 5) Enzyme Assay. Reagents for the EIA study were obtained from Syva Corp., Palo Alto, Calif. The method employs a bacterial glucose-6-phosphate dehydrogenase enzyme to which gentamicin has been linked. The active site of the enzyme is adjacent to the bound aminoglycoside. Antigentamicin antibody will bind to the gentamicin adjacent to the enzyme, thereby decreasing enzymatic activity. The assay follows the conversion of nicotinamide adenine dinucleotide to reduced nicotinamide adenine dinucleotide which occurs when the enzyme is able to act on a substrate. Free gentamicin in standards or from a sample competes for antibodies with drug bound to the enzyme. When less antibody blocks the active site of the glucose 6-phosphate dehydrogenase, the activity of the enzyme is increased.
With a pipetter-diluter, 50 The effect of heparin upon the EIA and RIA tests was determined. Gentamicin serum levels were lower by 0.43 ,ug/ml for the RIA and 0.45 ,ug/ml for the EIA when heparin-containing tubes were used to collect blood in comparison to the levels obtained from serum drawn at the same time. To see if the same serum level was obtained by RIA and EIA when the serum contained both gentamicin and 8B-lactam compounds, assays were made of mixtures stored at room temperature for 72 h. There was no statistical difference between the first value and the 72-h value for either method. Sera (111 samples) from 51 patients were analyzed by both methods. The coefficient of correlation for the methods was 0.97 (Fig. 2) . The level of gentamicin was less than 1 ug/ml for 17 VOL. 11, 1980 With the EIA, the delay time between obtaining the sample and the return of an assay result to the physician may be 30 min, a delay acceptable in a decision-making situation.
Compared with RIA, the EIA for gentamicin was simpler and had no radioactive waste. Also, EIA requires only 50 ,ll of serum, a useful characteristic in pediatric situations. The precision and specificity of the EIA and the RIA were similar, but in this study the EIA accuracy was better. For laboratories already using the same instrumentation to measure other drugs, the EIA certainly would be a preferable method for determining serum gentamicin levels. For other laboratories considering which system to use, the EIA offers an alternative to the currently available methods. 
